Skip to main navigation Skip to search Skip to main content

Anti-CD3-antikörper reduzieren langfristig den insulinbedarf bei neumanifestem typ-1-diabetes

Translated title of the contribution: Long-term reduction of the need of insulin in newly diagnosed type 1 diabetes with anti-CD3 antibodies
  • City Hospital Munich-Schwabing

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations
Translated title of the contributionLong-term reduction of the need of insulin in newly diagnosed type 1 diabetes with anti-CD3 antibodies
Original languageGerman
Pages (from-to)219-220
Number of pages2
JournalDiabetes und Stoffwechsel
Volume14
Issue number4
StatePublished - 2005
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this